Cargando…
Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages
Autores principales: | Wang, Zhenfeng, Zhou, Yabo, Bao, Linlin, Li, Dan, Lv, Jiadi, Wang, Dianheng, Li, Shunshun, Liu, Jiangning, Qin, Chuan, Tong, Wei-Min, Huang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984664/ https://www.ncbi.nlm.nih.gov/pubmed/35387969 http://dx.doi.org/10.1038/s41392-022-00977-1 |
Ejemplares similares
-
Escaping alveolar macrophage endosomal retention explains massive expansion of SARS-CoV-2 delta variant
por: Wang, Zhenfeng, et al.
Publicado: (2021) -
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
por: Wang, Zhenfeng, et al.
Publicado: (2022) -
YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation
por: Lv, Jiadi, et al.
Publicado: (2023) -
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
por: Lv, Jiadi, et al.
Publicado: (2021) -
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
por: Wang, Zhenfeng, et al.
Publicado: (2022)